Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ Efficacy and Safety Study in Healthy Chinese Women
NCT00819312Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in unintended pregnancy, sponsored by Bayer. Started Dec 2008; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT00819312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819312.